MAXIPHARMA A/S: Financial statements 2019
CVR: 87375617
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
MAXIPHARMA A/S (CVR 87375617) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,431,930 and a net result of DKK 773,998 compared with DKK -101,753 the year before. That is a decrease of 11.1% compared with the year before. Equity in the 2019 report amounted to DKK 2,848,223. The solvency ratio was 56%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,431,930
- Profit/Loss
- DKK 773,998
- Equity
- DKK 2,848,223
- Total Assets
- DKK 5,083,756
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 1.4 mio. | 774 t. | 2.8 mio. | 2 |
| 2018 | - | 1.6 mio. | -102 t. | 2.1 mio. | 2 |
| 2017 | - | 1.4 mio. | 323 t. | 2.4 mio. | 2 |
| 2016 | - | 1.5 mio. | 556 t. | 2.8 mio. | 2 |
| 2015 | - | 1.2 mio. | -188 t. | 2.2 mio. | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
MAXIPHARMA A/S has published its annual report for 2018. Gross profit came to DKK 1,611,487, and the net result was DKK -101,753.
About MAXIPHARMA A/S
MAXIPHARMA A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1979. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jesper Bjerre Jensen. The board consists of Benedikte Mailand Jensen (chair), Henrik Bencke and Jesper Bjerre Jensen. The company is owned by AKTIESELSKABET SGJ. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 1,791,625 and a net result of DKK 434,996 compared with DKK 411,322 the year before. Equity in the 2025 report amounted to DKK 4,204,696.